Skip to content

*Cost-effectiveness study of the HEART score in the management of patients with chest pain presenting in the emergency room*

*Cost-effectiveness study of the HEART score in the management of patients with chest pain presenting in the emergency room* - Cost-effectiveness of the HEART score in chest pain patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON39519
Enrollment
6600
Registered
2013-02-05
Start date
2013-07-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease occlusion of the arteries of the heart

Interventions

The HEART score is a validated risk score for all patients presenting with chest pain at the ED. The HEART score consists of the following clinical elements: History, ECG, Age, Risk factors and Trop

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patient presenting with chest pain at the emergency room

Exclusion criteria

Exclusion criteria: Children (age

Design outcomes

Primary

MeasureTime frame
All patients will be followed for three months to assess the study outcome parameters. Primary outcome: occurrence of MACE (i.e. acute myocardial infarction (AMI), Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG) or death) within 6 weeks after presentation (non-inferiority approach).

Secondary

MeasureTime frame
3 months incidence of MACE, quality of life and cost-effectiveness of the intervention compared with usual care. Furthermore, the number of missed events will be recorded. Also, we will be able to assess future biomarkers (like DNA-markers) in the extra bloodsample. furthermore, we will be able to assess possible women-specific risk factors by means of the women-specific questionnaire.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)